The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo (Q34989826)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q47262894)
(P304) 1895-1905
(P433) 7
(P478) 60
(P577) Wednesday, July 1, 2009
(P921) (Q269829)
(Q181600)
(Q187255)
(P1433) (Q4797636)
(P1476) "The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo" (language: en)
(P2093) Joel M Kremer
Bradley J Bloom
Ferdinand C Breedveld
John H Coombs
Mark P Fletcher
David Gruben
Sriram Krishnaswami
Rubén Burgos-Vargas
Bethanie Wilkinson
Cristiano A F Zerbini
Samuel H Zwillich
other details
description scientific article

External Links